Sandra Poole Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sandra Poole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sandra Poole. Sandra Poole is an Executive VP, Tech Operations in IMMUNOGEN INC ($IMGN) and a Senior VP, Tech Operations in IMMUNOGEN INC ($IMGN) and a Director in Retrophin, Inc. ($RTRX) and a Chief Operating Officer in LogicBio Therapeutics, Inc. ($LOGC).
Address: 830 WINTER STREET WALTHAM 02451 MA
Companies in which Sandra Poole is an Insider
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sandra Poole: Executive VP, Tech Operations, Senior VP, Tech Operations
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 20 2016
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LogicBio Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sandra Poole: Chief Operating Officer
Holdings: 0 shares
Latest Transaction: Oct 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sandra Poole: Director
Holdings: 6,500 shares
Current Value: $130,455
Latest Transaction: May 19 2020
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sandra Poole
Sentiment: All, IMGN, LOGC, RTRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2020 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Grant | A | 0.00 | 3,000 | 0 | 6,500 | 3.5 K to 6.5 K (+85.71 %) |
| May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Option Exercise | A | 17.87 | 14,000 | 250,180 | 14,000 | |
| May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
| Oct 22 2018 | LOGC | LogicBio Therapeut ... | Poole Sandra | Chief Operating Off ... | Option Exercise | A | 10.00 | 106,262 | 1,062,620 | 106,262 | |
| Oct 22 2018 | LOGC | LogicBio Therapeut ... | Poole Sandra | Chief Operating Off ... | Option Exercise | A | 10.00 | 106,262 | 1,062,620 | 106,262 | |
| Oct 20 2016 | IMGN | IMMUNOGEN INC | Poole Sandra | Executive VP, Tech ... | Option Exercise | A | 2.26 | 27,500 | 62,150 | 27,500 |